Drugs / Canadá
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05125978 | Sep 2026 → Jul 2028 | chronic pain syndrome | EMS | Withdrawn | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Canadá | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05125978 ↗ |
| Route | Oral | “1 tablet Canadá, oral;” NCT05125978 ↗ |